Bimatoprost Intracameral Implant (Durysta®): A New Era in Glaucoma Management Through Sustained-Release Innovation

Bimatoprost Intracameral Implant (Durysta®): A New Era in Glaucoma Management Through Sustained-Release Innovation

Iordanis Vagiakis,1 Eleni P Papadopoulou,1 Efstratia Amaxilati,1 Georgios N Tsiropoulos,1 Anastasios G Konstas,1,* Georgios D Panos1,2,* 1First Department of Ophthalmology, AHEPA University Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece; 2Div...

Full description

Saved in:
Bibliographic Details
Main Authors: Vagiakis I, Papadopoulou EP, Amaxilati E, Tsiropoulos GN, Konstas AG, Panos GD
Format: Article
Language:English
Published: Dove Medical Press 2025-01-01
Series:Drug Design, Development and Therapy
Subjects:
bimatoprost intracameral implant
glaucoma
intraocular pressure reduction
sustained-release therapy
primary open-angle glaucoma
ophthalmic drug delivery
patient adherence
prostaglandin analogs
endothelial cell safety
real-world evidence
cost-effectiveness
combination therapy in glaucoma
Online Access:https://www.dovepress.com/bimatoprost-intracameral-implant-durysta-a-new-era-in-glaucoma-managem-peer-reviewed-fulltext-article-DDDT
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/bimatoprost-intracameral-implant-durysta-a-new-era-in-glaucoma-managem-peer-reviewed-fulltext-article-DDDT

Similar Items